Revised WHO classification 2018 | Frequency (%)* | Five-year DSS (%) |
Cutaneous T cell and NK cell lymphomas |
Mycosis fungoides | 39 | 89 |
Mycosis fungoides variants and subtypes |
- Folliculotropic mycosis fungoides
| 5 | 79 |
| <1 | 100 |
| <1 | 100 |
Sézary syndrome | 2 | 30 |
Adult T cell leukemia/lymphoma | <1 | NDA |
Primary cutaneous CD30+ lymphoproliferative disorders |
- Primary cutaneous anaplastic large cell lymphoma
| 10 | 95 |
| 15 | 100 |
Subcutaneous panniculitis-like T cell lymphoma | 1 | 87 |
Extranodal NK/T cell lymphoma, nasal type | <1 | NR |
Primary cutaneous peripheral T cell lymphoma, rare subtypes |
- Primary cutaneous gamma-delta T cell lymphoma
| <1 | NR |
- Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma (provisional)
| <1 | 12 |
- Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoproliferative disorder (provisional)
| 3 | 100 |
- Primary cutaneous acral CD8+ T cell lymphoma (provisional)
| <1 | 100 |
Primary cutaneous peripheral T cell lymphoma, not otherwise specified | 2 | 15 |
Cutaneous B cell lymphomas |
Primary cutaneous marginal zone B cell lymphoma | 7 | 99 |
Primary cutaneous follicle center lymphoma | 12 | 95 |
Primary cutaneous diffuse large B cell lymphoma, leg type | 4 | 52 |